Should we be using calcium-containing phosphate binders in patients on dialysis?
Spiegel
David M
DM
Division of Renal Diseases and Hypertension at the University of Colorado Health Sciences Center, Denver, CO 80262, USA. david.spiegel@uchsc.edu
Block
Geoffrey A
GA
D017610:Calcium Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D002614:Chelating Agents / Q000627:therapeutic use*; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced / Q000517:prevention & control; D054559:Hyperphosphatemia / Q000517:prevention & control*; D006435:Renal Dialysis
D017610:Calcium Compounds; D002614:Chelating Agents